Literature DB >> 28396254

MutPred mutational load analysis shows mildly deleterious mitochondrial DNA variants are not more prevalent in Alzheimer's patients, but may be under-represented in healthy older individuals.

Ilse S Pienaar1, Neil Howell2, Joanna L Elson3.   

Abstract

Mitochondrial DNA (mtDNA) association studies have been conducted for over a decade using the haplogroup (lineage) association method, but this frequently produces conflicting results. Here we analyzed complete mtDNA sequence data of Alzheimer's disease (AD) patients and aged controls, from the United Kingdom (UK) and the United States (US), using a new "mutational load" method. We calculated a pathogenicity score for each of the non-synonymous substitutions of the mtDNA sequences to produce a "total mutational load" for each sequence, and compared the mutational loads of cases and controls. Using these mutational load measures, we found no evidence to support the cumulative role of mtDNA variants as a susceptibility factor in AD; that is, AD patients (UK and US cohorts) did not have higher "mutational loads" than controls. However, the US aged controls, who are significantly older than the UK ones, with many showing evidence of being healthy and having good cognition in old age, had significantly lower "mutational loads". This finding suggests that low mtDNA mutational load is more prevalent in healthy older people.
Copyright © 2017 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Mitochondrial DNA (mtDNA); MutPred; Mutational load; mtDNA population variation

Mesh:

Substances:

Year:  2017        PMID: 28396254     DOI: 10.1016/j.mito.2017.04.002

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  6 in total

Review 1.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

Review 2.  Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.

Authors:  Yunhua Peng; Peipei Gao; Le Shi; Lei Chen; Jiankang Liu; Jiangang Long
Journal:  Antioxid Redox Signal       Date:  2020-03-16       Impact factor: 8.401

3.  Mitochondrial DNA population variation is not associated with Alzheimer's in the Japanese population: A consistent finding across global populations.

Authors:  Johanna Wong; Jannetta S Steyn; Ilse S Pienaar; Joanna L Elson
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

Review 4.  Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.

Authors:  Wenzhang Wang; Fanpeng Zhao; Xiaopin Ma; George Perry; Xiongwei Zhu
Journal:  Mol Neurodegener       Date:  2020-05-29       Impact factor: 14.195

5.  MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants.

Authors:  Marianne Venter; Cara Tomas; Ilse S Pienaar; Victoria Strassheim; Elardus Erasmus; Wan-Fai Ng; Neil Howell; Julia L Newton; Francois H Van der Westhuizen; Joanna L Elson
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

6.  Mitochondrial genome variation in male LHON patients with the m.11778G > A mutation.

Authors:  Agnieszka Piotrowska-Nowak; Maciej R Krawczyński; Ewa Kosior-Jarecka; Anna M Ambroziak; Magdalena Korwin; Monika Ołdak; Katarzyna Tońska; Ewa Bartnik
Journal:  Metab Brain Dis       Date:  2020-08-01       Impact factor: 3.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.